Activation of the JAK/STAT Pathway Leads to BRAF Inhibitor Resistance in BRAFV600E Positive Thyroid CarcinomaJessica Limberg, Irene M. Min, Caitlin E. Egan et al.|Molecular Cancer Research|2023Cited by 24
Ablation therapy using a low dose of radioiodine may be sufficient in low- to intermediate-risk patients with follicular variant papillary thyroid carcinomaFuxin Li, Thomas J. Fahey, Wei Li et al.|Journal of International Medical Research|2020Cited by 7
Supplementary Figures 1-7 from Activation of the JAK/STAT Pathway Leads to BRAF Inhibitor Resistance in BRAF<sup>V600E</sup> Positive Thyroid CarcinomaJessica Limberg, Irene M. Min, Caitlin E. Egan et al.|Unknown|2023Cited by 0
Supplementary Figures 1-7 from Activation of the JAK/STAT Pathway Leads to BRAF Inhibitor Resistance in BRAF<sup>V600E</sup> Positive Thyroid CarcinomaJessica Limberg, Irene M. Min, Caitlin E. Egan et al.|Unknown|2023Cited by 0
Supplementary Tables 1-5 from Activation of the JAK/STAT Pathway Leads to BRAF Inhibitor Resistance in BRAF<sup>V600E</sup> Positive Thyroid CarcinomaJessica Limberg, Irene M. Min, Caitlin E. Egan et al.|Unknown|2023Cited by 0